Outcome after traumatic brain injury (TBI) depends on the extent of primary cell death and on the development of secondary brain injury. The general aim of this thesis was to find strategies and quality systems to minimize the extent of secondary insults in neurointensive care (NIC). An established standardized management protocol system, multimodality monitoring and computerized data collection, and analysis systems were used. The Uppsala TBI register was established for regular monitoring of NIC quality indexes. For 2008-2010 the proportion of patients improving during NIC was 60-80%, whereas 10% deteriorated. The percentage of ‘talk and die’ cases was < 1%. The occurrences of secondary insults were less than 5% of good monitoring time (GMT) for intracranial pressure (ICP) > 25 mmHg, cerebral perfusion pressure (CPP) < 50 mmHg and systolic blood pressure < 100 mmHg. Favorable outcome was achieved by 64% of adults. Nurse checklists of secondary insult occurrence were introduced. Evaluation of the use of nursing checklists showed that the nurses documented their assessments in 84-85% of the shifts and duration of monitoring time at insult level was significantly longer when secondary insults were reported regarding ICP, CPP and temperature. The use of nurse checklist was found to be feasible and accurate.  A clinical tool to avoid secondary insults related to nursing interventions was developed. Secondary brain insults occurred in about 10% of nursing interventions. There were substantial variations between patients. The risk ratios of developing an ICP insult were 4.7 when baseline ICP ≥ 15 mmHg, 2.9 when ICP amplitude ≥ 6 mmHg and 1.7 when pressure autoregulation ≥ 0.3. Hyperthermia, which is a known frequent secondary insult, was studied. Hyperthermia was most common on Day 7 after admission and 90% of the TBI patients had hyperthermia during the first 10 days at the NIC unit. The effects of hyperthermia on intracranial dynamics (ICP, brain energy metabolism and BtipO2) were small but individual differences were observed. Hyperthermia increased ICP slightly more when temperature increased in the groups with low compliance and impaired pressure autoregulation. Ischemic pattern was never observed in the microdialysis samples. The treatment of hyperthermia may be individualized and guided by multimodality monitoring.

L'intérêt du suivi du métabolisme énergétique cérébral dans la prise en charge des patients victimes d'hémorragie sous-arachnoïdienne anévrismale (aSAH) grave reste actuellement controversé en raison de l'absence de valeurs seuils décisionnelles applicables en pratique. Ce travail avait pour objectif de réévaluer l'intérêt des paramètres biochimiques de trois techniques, la microdialyse intracérébrale (cMD), la mesure de la pression tissulaire cérébrale en oxygène (PbtO2) et le cathéter rétrograde jugulaire, pour prédire l’issue fonctionnelle de ces patients et diagnostiquer la survenue d'un infarctus. Il parait évident que ce suivi peut permettre de prédire à l'échelon individuel l'issue fonctionnelle à long terme. Le metabolic ratio (MR) ou l'association de ce MR avec des paramètres des deux autres techniques (ratio Lactate/Pyruvate >40, lactates hypoxiques) représentent des potentiels biomarqueurs pronostiques. Il est en revanche difficile de conclure sur l'intérêt de ce suivi pour diagnostiquer les complications ischémiques secondaires. Bien qu'il ait été montré que le MR peut être considéré comme un biomarqueur, il n'est pas possible de conclure actuellement sur les deux approches locales (cMD et PbtO2). Des règles d'implantation ont tout de même pu être identifiées et validées permettant leur application rapide en pratique courante. Au final, le suivi du métabolisme énergétique cérébral doit être envisagé dans la prise en charge des patients aSAH graves notamment pour prédire l'issue fonctionnelle à long terme car des valeurs seuils décisionnelles ont été identifiées et faciliteront ainsi l'utilisation de ce type de monitoring / The interest of cerebral energy metabolism monitoring in the care of patients suffering from aneurysmal subarachnoid hemorrhage (aSAH) currently remains controversial because of the absence of decision making thresholds applicable in practice. This work aimed to reassess the value of biochemical parameters from three techniques, intracerebral microdialysis (cMD), the measurement of brain tissue oxygen pressure (PbtO2), the retrograde jugular catheter to predict the functional outcome and diagnose the occurrence of secondary ischemia.It seems obvious that this monitoring can predict at the individual level the functional long-term outcome. The metabolic ratio (MR) or association of MR with the parameters of the two other techniques (lactate/pyruvate >40, hypoxic lactate) represent potential prognostic biomarkers.It is however difficult to conclude on the interest of such monitoring to diagnose secondary ischemic complications. Although it has been shown that the MR can be considered as a biomarker, it is currently not possible to conclude on the two local approaches (cMD and PbtO2). Nevertheless, implantation rules have been identified and validated for their rapid application in clinical practice.Finally, the monitoring of brain energy metabolism remains a reference technique in the care of serious aSAH patients, especially to predict functional long-term outcome because decision thresholds have been identified and thus will facilitate the use of this kind of monitoring